Inventor · disambiguated record
Ulrich Bogdahn
Also filed as: BOGDAHN ULRICH · BOGDAHN ULRICH PROF DR
5 granted patents·2 pending applications·95 citations·filing 1994–2011
82Inventor score
Technology areasA61P
Top patents by PatentIndex Score
7 records- 0188US7667027B2Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 2006·Granted Feb 23, 2010·15 cites·2 claims
- 0284US6455689B1Antisense-oligonucleotides for transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 1994·Granted Sep 24, 2002·49 cites·6 claims
- 0379US8283334B2Inhibitors of TGF-R signaling for treatment of CNS disordersBOGDAHN ULRICH·Filed 2011·Granted Oct 9, 2012·7 cites·4 claims
- 0477US8022045B1Inhibitors of TGF-R-signaling for treatment of CNS disordersBOGDAHN ULRICH·Filed 2005·Granted Sep 20, 2011·5 cites·4 claims
- 0560US5770366AMelanoma-inhibiting proteinBOEHRINGER MANNHEIM GMBH·Filed 1994·Granted Jun 23, 1998·19 cites·27 claims
- 0648US2003040499A1Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta)BIOGNOSTIK GES·Filed 2002·Application pending·0 cites
- 0732US2006252716A1Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"SCHLINGENSIEPEN KARL-HERMANN·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Bogdahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →